Increased p21 expression and complex formation with cyclin E/CDK2 in retinoid-induced pre-B lymphoma cell apoptosis

FEBS Letters

Volumn 580, Issue 15, 2006, Pages 3687-3693

  Bao, George C ^a   Wang, Jian Guang ^a,b   Jong, Ambrose ^a,c  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Apoptosis; CDK2 activity; p21 induction; p21 CDK2 interaction; Retinoid

Indexed keywords

CASPASE 3; CYCLIN DEPENDENT KINASE 2; CYCLIN E; PROTEIN P21; RETINOIC ACID; RETINOID;

APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CELL DEATH; CELL PROLIFERATION; COMPLEX FORMATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LYMPHOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; UPREGULATION;

APOPTOSIS; CELL LINE, TUMOR; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOMA, B-CELL; MULTIPROTEIN COMPLEXES; PROTEIN BINDING; RECEPTORS, RETINOIC ACID; TRETINOIN;

EID: 33745164230     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.05.052     Document Type: Article

References (55)

1. Evans T. Regulation of hematopoiesis by retinoid signaling. Exp. Hematol. 33 (2005) 1055-1061
2. Altucci L., and Gronemeyer H. Decryption of the retinoid death code in leukemia. J. Clin. Immunol. 22 (2002) 117-123
3. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J. 10 (1996) 940-954
4. Kastner P., Mark M., Ghyselinck N., Krezel W., Dupe V., Grondona J.M., and Chambon P. Genetic evidence that the retinoid signal is transduced by heterodimeric RXR/RAR functional units during mouse development. Development 124 (1997) 313-326
5. Bastien J., and Rochette-Egly C. Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene 328 (2004) 1-16
6. Rochette-Egly C., Adam S., Rossignol M., Egly J.M., and Chambon P. Stimulation of RAR alpha activation function AF-1 through binding to the general transcription factor TFIIH and phosphorylation by CDK7. Cell 90 (1997) 97-107
7. Wang J., Barsky L.W., Shum C.H., Jong A., Weinberg K.I., Collins S.J., Triche T.J., and Wu L. Retinoid-induced G1 arrest and differentiation activation are associated with a switch to cyclin-dependent kinase-activating kinase hypophosphorylation of retinoic acid receptor alpha. J. Biol. Chem. 277 (2002) 43369-43376
8. Zhang S., He Q., Peng H., Tedeschi-Blok N., Triche T.J., and Wu L. MAT1-Modulated Cyclin-Dependent Kinase-Activating Kinase Activity Cross-Regulates Neuroblastoma Cell G(1) Arrest and Neurite Outgrowth. Cancer Res. 64 (2004) 2977-2983
9. Zhu J., Gianni M., Kopf E., Honore N., Chelbi-Alix M., Koken M., Quignon F., Rochette-Egly C., and de The H. Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor alpha (RARalpha) and oncogenic RARalpha fusion proteins. Proc. Natl. Acad. Sci. USA 96 (1999) 14807-14812
10. He Q., Peng H., Collins S.J., Triche T.J., and Wu L. Retinoid-modulated MAT1 ubiquitination and CAK activity. FASEB J. 18 (2004) 1734-1736
11. Liu M., Iavarone A., and Freedman L.P. Transcriptional activation of the human p21(WAF1/CIP1) gene by retinoic acid receptor. Correlation with retinoid induction of U937 cell differentiation. J. Biol. Chem. 271 (1996) 31723-31728
12. Sherr C.J., and Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13 (1999) 1501-1512
13. Coqueret O. New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment?. Trends Cell Biol. 13 (2003) 65-70
14. Chen J., Jackson P.K., Kirschner M.W., and Dutta A. Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA. Nature 374 (1995) 386-388
15. Goubin F., and Ducommun B. Identification of binding domains on the p21Cip1 cyclin-dependent kinase inhibitor. Oncogene 10 (1995) 2281-2287
16. Luo Y., Hurwitz J., and Massague J. Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1. Nature 375 (1995) 159-161
17. Warbrick E., Lane D.P., Glover D.M., and Cox L.S. A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigen. Curr. Biol. 5 (1995) 275-282
18. Nakanishi M., Robetorye R.S., Adami G.R., Pereira-Smith O.M., and Smith J.R. Identification of the active region of the DNA synthesis inhibitory gene p21Sdi1/CIP1/WAF1. EMBO J. 14 (1995) 555-563
19. Fotedar R., Fitzgerald P., Rousselle T., Cannella D., Doree M., Messier H., and Fotedar A. p21 contains independent binding sites for cyclin and cdk2: both sites are required to inhibit cdk2 kinase activity. Oncogene 12 (1996) 2155-2164
20. Fotedar R., Diederich L., and Fotedar A. Apoptosis and the cell cycle. Prog. Cell Cycle Res. 2 (1996) 147-163
21. Guo M., and Hay B.A. Cell proliferation and apoptosis. Curr. Opin. Cell Biol. 11 (1999) 745-752
22. Melnick A., and Licht J.D. Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 93 (1999) 3167-3215
23. Sundaresan A., Claypool K., Mehta K., Lopez-Berestein G., Cabanillas F., and Ford Jr. R.J. Retinoid-mediated inhibition of cell growth with stimulation of apoptosis in aggressive B-cell lymphomas. Cell Growth Differ. 8 (1997) 1071-1082
24. Guidoboni M., Zancai P., Cariati R., Rizzo S., Dal Col J., Pavan A., Gloghini A., Spina M., Cuneo A., Pomponi F., Bononi A., Doglioni C., Maestro R., Carbone A., Boiocchi M., and Dolcetti R. Retinoic acid inhibits the proliferative response induced by CD40 activation and interleukin-4 in mantle cell lymphoma. Cancer Res. 65 (2005) 587-595
25. Leclerc G.J., Leclerc G.M., and Barredo J.C. Real-time RT-PCR analysis of mRNA decay: half-life of Beta-actin mRNA in human leukemia CCRF-CEM and Nalm-6 cell lines. Cancer Cell Int. 2 (2002) 1
26. Wu L., Chen P., Hwang J.J., Barsky L.W., Weinberg K.I., Jong A., and Starnes V.A. RNA antisense abrogation of MAT1 induces G1 phase arrest and triggers apoptosis in aortic smooth muscle cells. J. Biol. Chem. 274 (1999) 5564-5572
27. Wang B., Feng L., Hu Y., Huang S.H., Reynolds C.P., Wu L., and Jong A.Y. The essential role of Saccharomyces cerevisiae CDC6 nucleotide-binding site in cell growth, DNA synthesis, and Orc1 association. J. Biol. Chem. 274 (1999) 8291-8298
28. Elsasser S., Lou F., Wang B., Campbell J.L., and Jong A. Interaction between yeast Cdc6 protein and B-type cyclin/Cdc28 kinases. Mol. Biol. Cell. 7 (1996) 1723-1735
29. Aguanno S., Bouche M., Adamo S., and Molinaro M. 12-O-tetradecanoylphorbol-13-acetate-induced differentiation of a human rhabdomyosarcoma cell line. Cancer Res. 50 (1990) 3377-3382
30. Bouche M., Senni M.I., Grossi A.M., Zappelli F., Polimeni M., Arnold H.H., Cossu G., and Molinaro M. TPA-induced differentiation of human rhabdomyosarcoma cells: expression of the myogenic regulatory factors. Exp. Cell Res. 208 (1993) 209-217
31. Benoit G.R., Flexor M., Besancon F., Altucci L., Rossin A., Hillion J., Balajthy Z., Legres L., Segal-Bendirdjian E., Gronemeyer H., and Lanotte M. Autonomous rexinoid death signaling is suppressed by converging signaling pathways in immature leukemia cells. Mol. Endocrinol. 15 (2001) 1154-1169
32. Wyllie A.H., Morris R.G., Smith A.L., and Dunlop D. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J. Pathol. 142 (1984) 67-77
33. Compton M.M. A biochemical hallmark of apoptosis: internucleosomal degradation of the genome. Cancer Metast. Rev. 11 (1992) 105-119
34. Kopf E., Plassat J.L., Vivat V., de The H., Chambon P., and Rochette-Egly C. Dimerization with retinoid X receptors and phosphorylation modulate the retinoic acid-induced degradation of retinoic acid receptors alpha and gamma through the ubiquitin-proteasome pathway. J. Biol. Chem. 275 (2000) 33280-33288
35. Tanaka T., Rodriguez de la Concepcion M.L., and De Luca L.M. Involvement of all-trans-retinoic acid in the breakdown of retinoic acid receptors alpha and gamma through proteasomes in MCF-7 human breast cancer cells. Biochem. Pharmacol. 61 (2001) 1347-1355
36. el-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., and Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 75 (1993) 817-825
37. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell 88 (1997) 323-331
38. Cox L.S. Multiple pathways control cell growth and transformation: overlapping and independent activities of p53 and p21Cip1/WAF1/Sdi1. J. Pathol. 183 (1997) 134-140
39. Filippini G., Balmelli T., Eppenberger H., and Soldati G. Flow cytometric detection of p53 protein after incubation of a pre-B cell line with antitumor agents. Cytometry 35 (1999) 267-273
40. Roninson I.B. Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts. Cancer Lett. 179 (2002) 1-14
41. Asada M., Yamada T., Ichijo H., Delia D., Miyazono K., Fukumuro K., and Mizutani S. Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation. EMBO J. 18 (1999) 1223-1234
42. Suzuki A., Tsutomi Y., Akahane K., Araki T., and Miura M. Resistance to Fas-mediated apoptosis: activation of caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP. Oncogene 17 (1998) 931-939
43. Meikrantz W., Gisselbrecht S., Tam S.W., and Schlegel R. Activation of cyclin A-dependent protein kinases during apoptosis. Proc. Natl. Acad. Sci. USA 91 (1994) 3754-3758
44. Hoang A.T., Cohen K.J., Barrett J.F., Bergstrom D.A., and Dang C.V. Participation of cyclin A in Myc-induced apoptosis. Proc. Natl. Acad. Sci. USA 91 (1994) 6875-6879
45. Polyak K., Lee M.H., Erdjument-Bromage H., Koff A., Roberts J.M., Tempst P., and Massague J. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78 (1994) 59-66
46. Toyoshima H., and Hunter T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78 (1994) 67-74
47. Lin R.J., Sternsdorf T., Tini M., and Evans R.M. Transcriptional regulation in acute promyelocytic leukemia. Oncogene 20 (2001) 7204-7215
48. Dilworth F.J., and Chambon P. Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription. Oncogene 20 (2001) 3047-3054
49. Glass C.K., and Rosenfeld M.G. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 14 (2000) 121-141
50. Aranda A., and Pascual A. Nuclear hormone receptors and gene expression. Physiol. Rev. 81 (2001) 1269-1304
51. Rosenauer A., Raelson J.V., Nervi C., Eydoux P., DeBlasio A., and Miller Jr. W.H. Alterations in expression, binding to ligand and DNA, and transcriptional activity of rearranged and wild-type retinoid receptors in retinoid-resistant acute promyelocytic leukemia cell lines. Blood 88 (1996) 2671-2682
52. Kinjo K., Miyakawa Y., Uchida H., Kitajima S., Ikeda Y., and Kizaki M. All-trans retinoic acid directly up-regulates thrombopoietin transcription in human bone marrow stromal cells. Exp. Hematol. 32 (2004) 45-51
53. Jiang H., Lin J., Su Z.Z., Collart F.R., Huberman E., and Fisher P.B. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 9 (1994) 3397-3406
54. Casini T., and Pelicci P.G. A function of p21 during promyelocytic leukemia cell differentiation independent of CDK inhibition and cell cycle arrest. Oncogene 18 (1999) 3235-3243
55. Dimberg A., and Oberg F. Retinoic acid-induced cell cycle arrest of human myeloid cell lines. Leuk. Lymphoma 44 (2003) 1641-1650